Addictions Therapeutics Market Analysis Report 2023-2027: 

The addiction therapeutics market size is estimated to grow at a CAGR of 7.65% between 2022 and 2027. The addiction therapeutics market size is forecast to increase by USD 9.86 billion. The growth of the market depends on several factors, including the high consumption of alcohol, tobacco, and opioid products, the approval of new drugs and the launch of digital therapeutics to treat addiction, and the initiatives to increase awareness about and combat addiction. 

This market size report extensively covers market segmentation by distribution channel (hospital pharmacy, retail pharmacy, and others), type (alcohol addiction therapeutics, tobacco addiction therapeutics, and drug addiction therapeutics), and geography (North America, Europe, Asia, and the Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

  What will the size of the Addictions Therapeutics Market be During the Forecast Period?

Addictions Therapeutics Market Size

To learn more about this report, View Report Sample

Addictions Therapeutics Market: Key Drivers, Trends, Challenges, and Customer Landscape

The high consumption of alcohol, tobacco, and opioid products is notably driving the addiction therapeutics market growth, although factors such as the presence of generics may impede the market growth.  Our researchers studied the data for years, with 2022 as the base year, and 2023 as the estimated year, and presented the key drivers, trends, and challenges for the market. Although there has been a decrease in demand for the market during the COVID-19 pandemic, a holistic analysis of drivers will help companies refine marketing strategies to gain a competitive advantage.   

Key Addictions Therapeutics Market Driver

One of the key factors driving growth in the addiction therapeutics market is the high consumption of alcohol, tobacco, and opioid products. The high consumption of alcohol, tobacco, and opioids globally drives the growth of the global addiction therapeutics market. Despite increasing awareness about and stringent regulations on the consumption of these products, the market has witnessed an increase in the consumption of alcohol, opioids, and tobacco products. Opioids are a type of narcotic pain medication that is available as a therapy for the treatment of moderate-to-severe pain in many developed countries.

However, the misuse and abuse of opioids lead to opioid tolerance and addiction. The high consumption of alcohol, tobacco, and opioid products on a daily basis can lead to a strong desire or sense of compulsion to consume the substance. This results in complications in controlling substance use behavior in terms of its onset, termination, and levels of use, which leads to substance use disorder, also known as substance dependency. Owing to the high consumption of these substances, the prevalence of substance use disorders has increased globally. Hence, the high consumption of these substances increases the prevalence of addiction globally, thereby driving the market growth.

Key Addictions Therapeutics Market Trends

The increasing R&D of novel drugs is another factor supporting the addiction therapeutics market share growth in coming years. Due to the increasing consumption of alcohol, tobacco, and opioid products, the demand for novel therapeutics to treat substance use disorders has increased. Therefore, several vendors are focusing on the development of novel therapeutics to treat substance use disorders.